By Helgi Library - August 13, 2020
CVS Health made a net profit of USD 2,975 mil with revenues of USD 65,341 mil in 2Q2020, up by 53.7% and up by 3.01%, ...
By Helgi Library - August 13, 2020
CVS Health's operating cash flow stood at USD 7,119 mil in 2Q2020, up 33.4% when compared to the previous year. Historic...
By Helgi Library - October 12, 2020
CVS Health's total assets reached USD 235,495 mil at the end of 2Q2020, up 7.58% compared to the previous year. Cu...
| Profit Statement |
| Balance Sheet |
| Ratios |
| Valuation |
Get all company financials in excel:
Get all company financials in excel:
By Helgi Library - August 13, 2020
CVS Health made a net profit of USD 6,634 mil in 2019, up 1% compared to the previous year. Total sales reached USD 256,776 mil, which is up 32% when compared to the previous year. Historically, between 2000 and 2019, the company’s net profit reach...
By Helgi Library - August 13, 2020
CVS Health stock traded at USD 72.6 per share at the end 2019 translating into a market capitalization of USD 96,726 mil. Since the end of 2014, stock has depreciated by 13.1% representing an annual average growth of -2.78%. In absolute terms, the value...
By Helgi Library - August 13, 2020
CVS Health invested a total of USD 2,457 mil in 2019, up 20.6% compared to the previous year. Historically, between 2009 - 2019, the company's investments stood at a high of USD 2,525 mil in 2009 and a low of USD 1,868 mil in 2011. As...
By Helgi Library - August 13, 2020
CVS Health made a net profit of USD 6,634 mil in 2019, up 1% compared to the previous year. Historically, between 2000 and 2019, the company's net profit reached a high of USD 6,634 mil in 2019 and a low of USD -594 mil in 2018. The result implies a retur...
By Helgi Library - August 13, 2020
CVS Health's net debt stood at USD 80,946 mil and accounted for 126% of equity at the end of 2019. The ratio is up 12.0 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 126% in 2019 and a low of ...
By Helgi Library - August 13, 2020
CVS Health stock traded at USD 72.6 per share at the end 2019 implying a market capitalization of USD 96,726 mil. Since the end of 2014, stock has appreciated by -13.1% implying an annual average growth of -2.78% In absolute terms, the value of the company ...
By Helgi Library - August 13, 2020
CVS Health made a net profit of USD 6,634 mil with revenues of USD 256,776 mil in 2019, up by 1.00% and up by 32.0%, respectively, compared to the previous year. This translates into a net margin of 2.58%. Historically, between 2000 and 2019, the fi...
By Helgi Library - August 13, 2020
CVS Health stock traded at USD 72.6 per share at the end 2019 translating into a market capitalization of USD 96,726 mil. Since the end of 2014, the stock has depreciated by 13.1% representing an annual average growth of -2.78%. At the end of 2019, the f...
CVS Health Corporation is an integrated pharmacy health care provider. The Company's offerings include pharmacy benefit management services, mail order, retail and specialty pharmacy, disease management programs, and retail clinics. The Company operates drugstores throughout the U.S., the District of Columbia, and Puerto Rico. Company’s retail segment sells prescription and over-the-counter drugs, beauty and personal care products, and cosmetics; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to chronic care facilities and other care settings. At the end of 2019, it operated approximately 9,900 retail locations and 1,100 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies
CVS Health has been growing its sales by 13.0% a year on average in the last 5 years. EBITDA has grown on average by 12.1% a year during that time to total of USD 19,028 mil in 2019, or 7.41% of sales. That’s compared to 6.43% average margin seen in last five years.
The company netted USD 6,634 mil in 2019 implying ROE of 10.8% and ROCE of 3.65%. Again, the average figures were 11.1% and 4.98%, respectively when looking at the previous 5 years.
CVS Health’s net debt amounted to USD 80,946 mil at the end of 2019, or 126% of equity. When compared to EBITDA, net debt was 4.25x, up when compared to average of 4.06x seen in the last 5 years.
CVS Health stock traded at USD 72.6 per share at the end of 2019 resulting in a market capitalization of USD 96,726 mil. Over the previous five years, stock price fell by 13.1% or -2.78% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of 9.34x and price to earnings (PE) of 14.3x as of 2019.
Helgi Library 
